IART - Integra LifeSciences Holdings Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,188,236992,075882,734
Cost of Revenue435,511349,089326,542
Gross Profit752,725642,986556,192
Operating Expenses
Research Development63,45558,15550,895
Selling General and Administrative624,096455,629415,757
Non Recurring---
Total Operating Expenses---
Operating Income or Loss44,804115,34079,587
Income from Continuing Operations
Total Other Income/Expenses Net1,6008694,618
Earnings Before Interest and Taxes46,404116,20984,205
Interest Expense35,01925,80323,534
Income Before Tax11,38590,40660,671
Income Tax Expense-53,35815,84253,820
Minority Interest---
Net Income From Continuing Ops64,74374,5646,851
Non-recurring Events
Discontinued Operations---10,370
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income64,74374,564-3,519
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares64,74374,564-3,519